Holger Gerlach is a Senior Product Manager and Senior Team Leader at Boehringer Ingelheim since December 2017, where responsibilities include overseeing product transfer into production and managing life cycle processes for commercial products within the formulation department. Prior experience includes serving as Team Leader at Sandoz, leading drug product analytics with a focus on stability studies and maintaining compliance in the lab, and contributing to the first biosimilar submission in the US as a Specialist in drug product analytics. Holger has also held postdoctoral fellow positions at the University of Oxford and the Max-Planck Institute for Molecular Physiology, specializing in biomolecular characterization. Educational background includes a Ph.D. in Physical Biochemistry from the Max-Planck Institute and a Diploma in Biochemistry from Ruhr University Bochum.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
94 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.
Ad